Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorMclean Hospital

About this trial

This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study how hallucinations work in schizophrenia.

TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study the investigators will be stimulating the brain to learn more about how TMS might improve these symptoms of schizophrenia.

Eligibility criteria

Qualifiers

Diagnosis of schizophrenia or schizoaffective disorder

Disqualifiers

substance use disorder in past 3 months

ambidexterity

history of neurological disorder

history of head trauma resulting in loss of consciousness

Trial design

Treatments tested in this trial

  • Repetitive Transcranial Magnetic Stimulation (rTMS)
  • Sham Repetitive Transcranial Magnetic Stimulation (rTMS)

Treatment groups

68 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Mclean Hospital

Lead sponsor

Beth Israel Deaconess Medical Center

Collaborator

National Institute of Mental Health (NIMH)

Collaborator